Smith Asset Management Group LP bought a new stake in shares of Catalent Inc (NYSE:CTLT) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 47,910 shares of the company’s stock, valued at approximately $1,968,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CTLT. Zions Bancorporation bought a new position in Catalent in the 3rd quarter valued at $100,000. First Bank & Trust grew its position in Catalent by 54.2% in the 4th quarter. First Bank & Trust now owns 3,764 shares of the company’s stock valued at $155,000 after acquiring an additional 1,323 shares during the last quarter. Fortaleza Asset Management Inc. bought a new position in Catalent in the 3rd quarter valued at $164,000. CAPROCK Group Inc. bought a new position in Catalent in the 4th quarter valued at $203,000. Finally, Eagle Boston Investment Management Inc. bought a new position in Catalent in the 3rd quarter valued at $216,000. 99.82% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Catalent Inc (CTLT) opened at $42.84 on Monday. The company has a debt-to-equity ratio of 2.66, a quick ratio of 1.78 and a current ratio of 2.22. The firm has a market capitalization of $5,711.37, a price-to-earnings ratio of 26.77, a P/E/G ratio of 2.46 and a beta of 1.47. Catalent Inc has a 12 month low of $27.48 and a 12 month high of $47.87.
Several brokerages have commented on CTLT. Royal Bank of Canada set a $48.00 price objective on Catalent and gave the company a “buy” rating in a research report on Monday, February 5th. Zacks Investment Research cut Catalent from a “buy” rating to a “hold” rating in a report on Thursday, January 18th. Goldman Sachs Group initiated coverage on Catalent in a report on Wednesday, January 24th. They issued a “buy” rating and a $50.00 target price for the company. ValuEngine upgraded Catalent from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. Finally, Piper Jaffray Companies upped their target price on Catalent from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Tuesday, November 7th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $45.70.
In related news, insider John R. Chiminski sold 181,458 shares of the company’s stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $39.62, for a total transaction of $7,189,365.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.70% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Smith Asset Management Group LP Buys Shares of 47,910 Catalent Inc (CTLT)” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3223850/smith-asset-management-group-lp-buys-shares-of-47910-catalent-inc-ctlt.html.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.